Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life
about
Antigen-specific immunotherapy of cervical and ovarian cancerPerspectives for therapeutic HPV vaccine developmentRegulation of the lifespan in dendritic cell subsetsSingle-walled carbon nanotubes-mediated in vivo and in vitro delivery of siRNA into antigen-presenting cells.In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine.Perspectives for preventive and therapeutic HPV vaccines.Immunotherapy for cervical cancer: Research status and clinical potentialInhibitory RNA molecules in immunotherapy for cancer.Efficient delivery of DNA vaccines using human papillomavirus pseudovirionsDNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunityCo-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination.Harnessing DNA-induced immune responses for improving cancer vaccines.Immunological research using RNA interference technology.Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis.RNA as performance-enhancers for dendritic cells.Programmed cell death of dendritic cells in immune regulation.Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?siRNA and cancer immunotherapy.Current state in the development of candidate therapeutic HPV vaccinesThe current state of therapeutic and T cell-based vaccines against human papillomaviruses.Intratumor RNA interference of cell cycle genes slows down tumor progression.Blocking the immunosuppressive axis with small interfering RNA targeting interleukin (IL)-10 receptor enhances dendritic cell-based vaccine potency.Connective tissue growth factor linked to the E7 tumor antigen generates potent antitumor immune responses mediated by an antiapoptotic mechanism.Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments.Apoptosis-related mitochondrial dysfunction defines human monocyte-derived dendritic cells with impaired immuno-stimulatory capacities.Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?Regulation of Immune Responses by Spontaneous and T cell-mediated Dendritic Cell DeathTherapeutic vaccines for high-risk HPV-associated diseases.Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies.Extended Culture of Bone Marrow with Granulocyte Macrophage-Colony Stimulating Factor Generates Immunosuppressive Cells.Therapeutic human papillomavirus vaccines: current clinical trials and future directions
P2860
Q27488697-1FC492FE-8EC8-48B1-8CED-F69955E5BF07Q28069272-F38F83EC-D55B-49A9-ADB2-89ACD3B4AAF9Q28505315-F627C220-5494-4FD7-8903-F4C7F50275B6Q33250007-A1EFA2CC-793C-4C89-A45C-20695828B69CQ33767127-1CF036BD-63D2-41D8-B817-08EA620B850AQ34011494-95CF6329-7255-4FA6-8A40-104670223634Q34033763-0CCBA94B-E15F-4338-AA09-755E2685ABD6Q34033910-CFBF2A00-98A0-4E60-A83E-1CE219C5F3E5Q34274080-C847560C-D18B-441B-80E6-2C10CE530227Q35184078-1C6B102A-279C-4CD2-A622-85808307BCD9Q35782004-37B3CE77-4A24-41DB-B088-86E4C090ADB0Q36694866-6924CAF5-8193-43C6-9BEF-C50238D4BF55Q36788606-DA698894-0931-4344-9BCD-8F1127ED5346Q37579334-00C68C6A-C77B-4800-8ACC-50BEF36664FFQ37686532-7F2D6206-338B-466A-9FCB-517989423A67Q37773421-6992C6C8-6D07-43B1-9B09-10E3767C0CFCQ37800934-490AFE5A-319F-4B02-8855-8C6F08C2D683Q38050504-A76B1B3A-4F7F-4ED0-A6B1-317AB17A5BA0Q38743922-FE2559F3-D1E2-40B8-911F-9B521C27E466Q39033576-066983A6-A6E8-4E68-AE8D-57F09F0DBAD8Q39578441-88194A64-107C-457A-830D-A90A30A47DDDQ39749014-AA6B4148-7E18-4488-A1A9-856541C5F025Q39999888-1978FF43-85A0-4E6B-9E61-BB91BDC0EFD3Q40182110-B64D38EE-191A-43BA-A28A-0CF76DBC252DQ41211222-ED1D114A-8F7E-4DD9-8F62-2DF21E61CCC0Q41520681-D281627E-5740-477F-9427-DFDC59866D40Q41812910-0F117BB5-9C05-4FAF-AD80-522D6B6DDC5AQ47255618-243340E1-17EF-4108-B416-5E10D26E8656Q55003884-E565D825-69A7-4D43-BD41-F34429AD0418Q55255575-9A6739AB-84E2-40BB-A08F-9968611E5567Q56937332-F433A2DC-CA03-4B65-8CB8-4FF5A722CB8D
P2860
Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Vaccination with dendritic cel ...... prolonging dendritic cell life
@ast
Vaccination with dendritic cel ...... prolonging dendritic cell life
@en
type
label
Vaccination with dendritic cel ...... prolonging dendritic cell life
@ast
Vaccination with dendritic cel ...... prolonging dendritic cell life
@en
prefLabel
Vaccination with dendritic cel ...... prolonging dendritic cell life
@ast
Vaccination with dendritic cel ...... prolonging dendritic cell life
@en
P2093
P2860
P356
P1433
P1476
Vaccination with dendritic cel ...... prolonging dendritic cell life
@en
P2093
Chien-Fu Hung
Jin Hyup Lee
Liangmei He
Shiwen Peng
Tae Woo Kim
P2860
P304
P356
10.1089/HUM.2005.16.584
P577
2005-05-01T00:00:00Z